| 000 | 03930cam a2200901 a 4500 | ||
|---|---|---|---|
| 005 | 20250930145119.0 | ||
| 006 | m f d | ||
| 007 | cr cn ---uuauu | ||
| 008 | 100630q20062007nyua fsbf 000 0 eng d | ||
| 010 | _z2005-041665 | ||
| 020 | _z0071440860 (print) | ||
| 020 | _z9780071440868 (print) | ||
| 035 | _a(Sirsi) a215933 | ||
| 035 | _accn00215933 | ||
| 039 | 9 |
_y06-30-2010 _znona |
|
| 050 | 4 |
_aRC88.9.T47 _bG746 |
|
| 060 | 4 | _aWA 295 G844b | |
| 100 | 1 | _aGrey, Michael R. | |
| 245 | 1 | 4 |
_aThe bioterrorism sourcebook _h[electronic resource] / _cMichael R. Grey, Kenneth R. Spaeth. |
| 260 |
_aNew York : _bMcGraw-Hill. |
||
| 300 |
_a1 electronic text (xxxiii, 549 p.) : _bill. |
||
| 490 | 1 | _aMcGraw-Hill's AccessMedicine. Lange educational library | |
| 500 | _aTitles from cover image and table of contents, viewed on August 28, 2007. | ||
| 500 | _aPrint version c2006. | ||
| 504 | _aIncludes bibliographical references (p. 507-528). | ||
| 505 | 0 | _uhttp://www.loc.gov/catdir/enhancements/fy0623/2005041665-t.htm l | |
| 505 | 0 | _aBioterrorism timeline -- Section I. Clinical principles and practices -- Section II. Infectious agents -- Section III. Biotoxins and category B and C agents -- Section IV. Chemical weapons -- Section V. Nuclear and radiation syndromes -- Conclusion -- Definitions/abbreviations -- Dosing regimens -- Selected bibliography. | |
| 506 | _aFull text available with subscription to McGraw-Hill's AccessMedicine. | ||
| 530 | _aAlso issued in print. | ||
| 538 | _aMode of access: World Wide Web. | ||
| 545 | 0 |
_aContributor biographical information: _uhttp://www.loc.gov/catdir/enhancements/fy0739/2005041665-b.htm l |
|
| 650 | 0 |
_aTerrorism _xHealth aspects _xComputer network resources. |
|
| 650 | 1 | 2 | _aBioterrorism. |
| 650 | 2 | 2 | _aBacterial infections. |
| 650 | 2 | 2 | _aChemical Warfare Agents. |
| 650 | 2 | 2 | _aDisaster Planning. |
| 650 | 2 | 2 |
_aPublic health. _960785 |
| 655 | 0 | _aElectronic books. | |
| 655 | 0 | _aInternet resources. | |
| 700 | 1 | _aSpaeth, Kenneth R. | |
| 740 | 0 | 2 | _aIntroduction to terrorism and bioterrorism. |
| 740 | 2 | 2 | _aA clinical approach to biological, chemical, and nuclear terrorism. |
| 740 | 0 | 2 | _aClinicians' roles in public health preparedness and emergency response. |
| 740 | 0 | 2 | _aEnvironmental terrorism. |
| 740 | 0 | 2 | _aSurveillance systems and bioterrorism. |
| 740 | 0 | 2 | _aVulnerable groups: a summary of relevant concerns. |
| 740 | 0 | 2 | _aPsychological effects of the BCN threat. |
| 740 | 0 | 2 | _aToxicology and bioterrorism. |
| 740 | 0 | 2 | _aLegal and ethical issues. |
| 740 | 2 | 2 | _aA brief history of biological weapons. |
| 740 | 0 | 2 | _aIntroduction to biological agents. |
| 740 | 0 | 2 | _aSmallpox (Variola major) |
| 740 | 0 | 2 | _aViral hemorrhagic fevers. |
| 740 | 0 | 2 | _aAnthrax. |
| 740 | 0 | 2 | _aPlague (Yersinia pestis) |
| 740 | 0 | 2 | _aTularemia (Francisella tularensis) |
| 740 | 0 | 2 | _aIntroduction to biotoxins. |
| 740 | 0 | 2 | _aBotulinum toxin. |
| 740 | 0 | 2 | _aRicin. |
| 740 | 0 | 2 | _aCategory B and C and additional agents. |
| 740 | 0 | 2 | _aIntroduction to chemical weapons. |
| 740 | 2 | 2 | _aA brief history of chemical weapons. |
| 740 | 0 | 2 | _aPulmonary agents. |
| 740 | 0 | 2 | _aVesicants or blistering agents. |
| 740 | 0 | 2 | _aNerve and incapacitating agents. |
| 740 | 0 | 2 | _aBlood agents. |
| 740 | 2 | 2 | _aA brief history of nuclear weapons and the atomic age. |
| 740 | 3 | 2 | _aAn overview of radiation physics and injury. |
| 740 | 0 | 2 | _aIntroduction to nuclear and radiation weapons. |
| 740 | 0 | 2 | _aRadiologic terrorism. |
| 830 | 0 |
_aMcGraw-Hill's AccessMedicine. _pLange educational library. |
|
| 856 | 4 | 0 |
_uhttps://eresourcesptsl.ukm.remotexs.co/login?url=http://www.accessmedicine.com/resourceTOC.aspx?resourceID=95 _zSubscription required |
| 907 |
_a.b14759263 _b2022-04-06 _c2019-11-12 |
||
| 942 | _n0 | ||
| 914 | _avtls003436909 | ||
| 998 |
_ae _b2010-04-06 _cm _dz _feng _gnyu _y0 _z.b14759263 |
||
| 999 |
_c679403 _d679403 |
||